SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--In the rarified world of protein crystal hunters, Fluidigm’s TOPAZ® system is the tool that has helped researchers solve the structures of proteins from ...
Collaboration will perform gene-expression analysis of tumors and evaluate changes in cancer stem cells when mAbs are used. OncoMed Pharmaceuticals is tapping Fluidigm’s microfluidic tools for the ...
BRANFORD, Conn. & SAN FRANCISCO--(BUSINESS WIRE)-- 454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the ...
Firms claim automated processing will minimize manual steps for targeted sequencing applications. Fluidigm and 454 Life Sciences have agreed to co-promote their respective and complementary ...
Senior Executive from Fortune 500 Company to Lead Business Development and Marketing for Integrated Fluidic Circuit Inventor SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation today ...
Fluidigm Corporation has introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour. The 192.24 ...
BRANFORD, Conn. & SAN FRANCISCO--(BUSINESS WIRE)-- 454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback